Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Cardiovascular Institute of the South Clinical Research Corporation
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Cardiovascular Institute of the South Clinical Research Corporation
ClinicalTrials.gov Identifier:
NCT01705509
First received: October 10, 2012
Last updated: January 24, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)